Erik Larsson
1 – 10 of 24
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
    
    
- Contribution to journal › Article
 
 - 2024
 - 
                        Mark
        Pareto optimization of SPECT acquisition and reconstruction settings for 177Lu activity quantification
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Bias and precision of SPECT-based 177Lu activity-concentration estimation using a ring-configured solid-state versus a dual-headed anger system
    
    
- Contribution to journal › Article
 
 - 2022
 - 
                        Mark
        Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
    
    
- Contribution to journal › Article
 
 - 2019
 - 
                        Mark
        Albumin infusion rate and plasma volume expansion : A randomized clinical trial in postoperative patients after major surgery
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
    
    
- Contribution to journal › Article
 
 - 2018
 - 
                        Mark
        Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours
    
    
- Contribution to journal › Article
 
 - 2016
 - 
                        Mark
        Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide 177Lu Compared to Alpha Particles and Gamma Rays.
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays
    
    
- Contribution to journal › Article
 
 
